Systemic and spinal administration of the mu opioid, remifentanil, produces antinociception in amphibians

Shekher Mohan, Craig W. Stevens

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Remifentanil is a relatively new opioid analgesic related to the fentanyl family of mu opioid receptor agonists and is used clinically for its unique property of having an ultra-short duration of action. However, there is little preclinical data on the analgesic (antinociceptive) effects of remifentanil and none obtained in non-mammalian animal models. The antinociceptive effects of remifentanil were assessed by using the acetic acid test in amphibians. Systemic and spinal administration of remifentanil was made by subcutaneous and intraspinal injections in the Northern grass frog, Rana pipiens. After administration, remifentanil produced dose-dependent and long-lasting antinociceptive effects which persisted for five hours after systemic administration but gave a shorter duration of action after spinal delivery. The antinociceptive effects of remifentanil were significantly blocked by pretreatment with systemic naltrexone. Systemic and spinal administration of remifentanil produced log dose-response curves which yielded ED50 values of 7.1 nmol/g and 3.2 nmol/animal respectively. The relative antinociceptive potency of remifentanil compared to other opioids administered to amphibians is similar to that found in mammalian models.

Original languageEnglish
Pages (from-to)89-94
Number of pages6
JournalEuropean Journal of Pharmacology
Volume534
Issue number1-3
DOIs
StatePublished - 18 Mar 2006

Fingerprint

Amphibians
Opioid Analgesics
Rana pipiens
Spinal Injections
Naltrexone
remifentanil
mu Opioid Receptor
Fentanyl
Subcutaneous Injections
Poaceae
Acetic Acid
Anura
Analgesics
Animal Models

Keywords

  • Analgesia
  • Mu opioid receptor
  • Opioid
  • Rana pipiens
  • Remifentanil

Cite this

@article{b4acc79952bd43c6af874e6b7d22d9bc,
title = "Systemic and spinal administration of the mu opioid, remifentanil, produces antinociception in amphibians",
abstract = "Remifentanil is a relatively new opioid analgesic related to the fentanyl family of mu opioid receptor agonists and is used clinically for its unique property of having an ultra-short duration of action. However, there is little preclinical data on the analgesic (antinociceptive) effects of remifentanil and none obtained in non-mammalian animal models. The antinociceptive effects of remifentanil were assessed by using the acetic acid test in amphibians. Systemic and spinal administration of remifentanil was made by subcutaneous and intraspinal injections in the Northern grass frog, Rana pipiens. After administration, remifentanil produced dose-dependent and long-lasting antinociceptive effects which persisted for five hours after systemic administration but gave a shorter duration of action after spinal delivery. The antinociceptive effects of remifentanil were significantly blocked by pretreatment with systemic naltrexone. Systemic and spinal administration of remifentanil produced log dose-response curves which yielded ED50 values of 7.1 nmol/g and 3.2 nmol/animal respectively. The relative antinociceptive potency of remifentanil compared to other opioids administered to amphibians is similar to that found in mammalian models.",
keywords = "Analgesia, Mu opioid receptor, Opioid, Rana pipiens, Remifentanil",
author = "Shekher Mohan and Stevens, {Craig W.}",
year = "2006",
month = "3",
day = "18",
doi = "10.1016/j.ejphar.2006.01.011",
language = "English",
volume = "534",
pages = "89--94",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

Systemic and spinal administration of the mu opioid, remifentanil, produces antinociception in amphibians. / Mohan, Shekher; Stevens, Craig W.

In: European Journal of Pharmacology, Vol. 534, No. 1-3, 18.03.2006, p. 89-94.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Systemic and spinal administration of the mu opioid, remifentanil, produces antinociception in amphibians

AU - Mohan, Shekher

AU - Stevens, Craig W.

PY - 2006/3/18

Y1 - 2006/3/18

N2 - Remifentanil is a relatively new opioid analgesic related to the fentanyl family of mu opioid receptor agonists and is used clinically for its unique property of having an ultra-short duration of action. However, there is little preclinical data on the analgesic (antinociceptive) effects of remifentanil and none obtained in non-mammalian animal models. The antinociceptive effects of remifentanil were assessed by using the acetic acid test in amphibians. Systemic and spinal administration of remifentanil was made by subcutaneous and intraspinal injections in the Northern grass frog, Rana pipiens. After administration, remifentanil produced dose-dependent and long-lasting antinociceptive effects which persisted for five hours after systemic administration but gave a shorter duration of action after spinal delivery. The antinociceptive effects of remifentanil were significantly blocked by pretreatment with systemic naltrexone. Systemic and spinal administration of remifentanil produced log dose-response curves which yielded ED50 values of 7.1 nmol/g and 3.2 nmol/animal respectively. The relative antinociceptive potency of remifentanil compared to other opioids administered to amphibians is similar to that found in mammalian models.

AB - Remifentanil is a relatively new opioid analgesic related to the fentanyl family of mu opioid receptor agonists and is used clinically for its unique property of having an ultra-short duration of action. However, there is little preclinical data on the analgesic (antinociceptive) effects of remifentanil and none obtained in non-mammalian animal models. The antinociceptive effects of remifentanil were assessed by using the acetic acid test in amphibians. Systemic and spinal administration of remifentanil was made by subcutaneous and intraspinal injections in the Northern grass frog, Rana pipiens. After administration, remifentanil produced dose-dependent and long-lasting antinociceptive effects which persisted for five hours after systemic administration but gave a shorter duration of action after spinal delivery. The antinociceptive effects of remifentanil were significantly blocked by pretreatment with systemic naltrexone. Systemic and spinal administration of remifentanil produced log dose-response curves which yielded ED50 values of 7.1 nmol/g and 3.2 nmol/animal respectively. The relative antinociceptive potency of remifentanil compared to other opioids administered to amphibians is similar to that found in mammalian models.

KW - Analgesia

KW - Mu opioid receptor

KW - Opioid

KW - Rana pipiens

KW - Remifentanil

UR - http://www.scopus.com/inward/record.url?scp=33644888256&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2006.01.011

DO - 10.1016/j.ejphar.2006.01.011

M3 - Article

C2 - 16487509

AN - SCOPUS:33644888256

VL - 534

SP - 89

EP - 94

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -